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Myelin basic protein (MBP) reduces the amount of phosphatase activity produced in the kinase FA-mediat- 
ed activation of the ATP,Mg-dependent phosphatase. MBP was shown not only to inhibit the activated 
enzyme, but also to impair the kinase FA-mediated activation of the inactive phosphatase. In addition MBP 
prevents the time-dependent inactivation of the catalytic subunit by the modulator protein. These observa- 
tions point to a regulatory role for MBP in the reversible activation of the ATP,Mg-dependent protein phos- 
phatase by kinase FA. 
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1. INTRODUCTION 
All animal tissues examined [l-3] contain the 
basic components required for the reversible ac- 
tivation of the ATP,Mg-dependent protein 
phosphatase (F,M): the 38 kDa catalytic subunit 
(F,), which interconverts between the inactive and 
activated conformation, and the 32 kDa 
modulator subunit (M), which mediates the 
activation-inactivation of the catalytic subunit and 
the protein kinase FA. The phosphorylation of the 
modulator by protein kinase FA is the first step in 
the activation of the ATP,Mg-dependent 
phosphatase [4]. Although the mechanism of the in 
vitro activation of the enzyme has been unravelled 
down to the molecular level [5-l 11, little or no in- 
formation is available at present about the 
physiological trigger for the in vivo activation or 
inactivation process. A regulation of the protein 
kinase FA activity itself is expected in view of the 
Correspondence address: J.R. Vandenheede, Afdeling 
Biochemie, Campus Gasthuisberg, K.U. Leuven, B-3000 
Leuven, Belgium 
opposite effects this enzyme can have on the 
phosphorylation state of glycogen synthase when it 
either acts as a synthase kinase or as the activating 
enzyme for a synthase phosphatase [1,121. The 
ATP,Mg-dependent protein phosphatase and pro- 
tein kinase FA can be used interchangeably between 
the different sources [l-3]. The ATP,Mg- 
dependent phosphatase not only has a wide tissue 
distribution, but it also dephosphorylates an im- 
pressive number of protein substrates [ 131, some of 
them, like phosphorylase, phosphorylase b kinase 
and glycogen synthase, being key enzymes in the 
hormonal and metabolic regulation of glycogen 
metabolism. 
Although glycogen metabolism appears to be 
quantitatively less important in brain than in 
skeletal muscle, it was recently reported that pig 
brain has a surprisingly high content of ATP,Mg- 
dependent phosphatase [2] and kinase FA [3]. MBP 
constitutes about 30% of the myelin protein and 
undergoes a fast phosphorylation turnover in vivo 
[14]. When phosphorylated either by cyclic AMP- 
dependent protein kinase or by protein kinase FA, 
it is an excellent substrate for the ATP,Mg- 
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dependent phosphatase [2]. In addition the 
phospho- and the dephospho forms of MBP are 
potent inhibitors of ATP,Mg-dependent phos- 
phorylase phosphatase activity [2]. 
Here, we have examined the possible role of 
MBP in the activation-inactivation of the 
ATP,Mg-dependent protein phosphatase. 
2. MATERIALS AND METHODS 
Materials and methods were essentially as 
described in [7,10,1 I]. The inactive ATP,Mg- 
dependent phosphatase [lo] had a specific activity 
of 25000 U/mg when measured after a 10 min 
preincubation at 30°C with kinase FA, 0.1 mM 
ATP and 0.5 mM Mg*+, using phosphorylase a 
(2 mg/ml) as substrate. One unit of phosphatase 
releases 1 nmol [32P]phosphate from 32P-labeled 
phosphorylase per min at 30°C. 
The heat-stable modulator [9], the active 
catalytic subunit of the ATP,Mg-dependent pro- 
tein phosphatase [151 and protein kinase FA [12] 
were isolated from rabbit skeletal muscle as 
described. MBP (Eli Lilly, lot P66520) was a 
generous gift from Dr R.L. Khandelwal (Saska- 
toon, Canada). Protamine, lysine-rich histones 
(type V-S) and polylysine (17 kDa) were from 
Sigma. 
To measure the activation of the ATP,Mg- 
dependent phosphatase or the intrinsic activity of 
the enzyme in the presence of inhibitory concentra- 
tions of MBP or modulator, a trypsin treatment 
was performed using 50 pg/ml of TPCK-treated 
trypsin (Sigma), to destroy both heat-stable pro- 
teins before the phosphatase assay. The proteolysis 
(2 min at 30°C) was stopped by the addition of an 
excess of soybean trypsin inhibitor (Sigma). Tryp- 
sin selectively destroys the inactive ATP,Mg- 
dependent phosphatase, but does not impair the 
activity of the activated enzyme [7,9,11]. 
3. RESULTS AND DISCUSSION 
3 .l . Effect of MBP on the activation and the 
activity of the ATP,Mg-dependent protein 
phosphatase 
Addition of increasing amounts of MBP (not 
phosphorylated) to the ATP,Mg-dependent 
phosphatase causes a dose-dependent decrease in 
the amount of phosphorylase phosphatase activity 
produced after incubation of the inactive enzyme 
with protein kinase FA in the presence of ATP,Mg 
(fig.lA). The decrease is not a simple inhibition of 
the phosphorylase phosphatase activity created in 
the activation step since it cannot be relieved by 
removal of the inhibitory MBP in a subsequent 
trypsin treatment (fig. 1A). An identical amount of 
ATP,Mg-dependent phosphatase previously ac- 
tivated by protein kinase FA is inhibited by similar 
concentrations of MBP, but this inhibition can be 
relieved by proteolytic destruction of the inhibitory 
protein (fig.lB). Activation of the ATP,Mg- 
dependent phosphatase by protein kinase FA 
generally produces more phosphorylase phos- 
phatase activity upon trypsin treatment, and this 
has been explained by the proteolytic destruction 
of some of the modulator bound at the inhibitory 
site on the enzyme [5,9,10]. The trypsinized ac- 
tivated ATP,Mg-dependent protein phosphatase is 
also completely inhibited by comparable concen- 
trations of non-phosphorylated MBP (fig. 1B). 
The observation that during activation of the 
ATP,Mg-dependent protein phosphatase less ac- 
MBP added ( pg Iastay ) 
Fig.1. Effect of MBP on the activation and the activity 
of the ATP,Mg-dependent protein phosphatase. (A) 
Activation of 150 mU F,M enzyme by 300 mU kinase FA 
in the presence of O-6 pg MBP in a 30 pl mixture. After 
preincubation at 30°C for 10 min, a lop1 aliquot was 
taken for the determination of the phosphorylase 
phosphatase activity (304) without (0) or after (0) a 
trypsin treatment as described in section 2. (B) Inhibition 
of 50 mU F,M enzyme, previously activated by 100 mU 
kinase FA without (0,o) or with a subsequent rypsin 
treatment (A), by O-2 pg MBP per 30 ~1 assay mixture. 
The phosphorylase phosphatase activities were 
determined after (0) or without (0, A) an additional 
trypsin treatment. 
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tivity is obtained in the presence of MBP, and that 
this loss of activity cannot be restored by trypsin 
treatment (fig.lA) points to the possibility that 
MBP may interfere in the activation of the 
phosphatase by protein kinase FA, thus reducing 
the amount of active enzyme produced. This idea 
was confirmed in the experiment shown in fig.2, 
where increasing amounts of kinase FA were able to 
restore the activation of the ATP,Mg-dependent 
phosphatase in the presence of a concentration of 
MBP which totally inhibits the potential activity of 
the enzyme. The amount of active phosphatase 
could be specifically measured after a subsequent 
trypsin treatment, which destroyed the MBP, the 
kinase FA and the left-over inactive phosphatase as 
mentioned in section 2. A similar inhibition of the 
activation of the ATP,Mg-dependent protein 
phosphatase can be seen by adding purified (free) 
modulator protein in the activation step (fig.2). 
The free modulator can also be considered as an 
alternative substrate for protein kinase FA. 
3.2. Effect of MBP on the active catalytic subunit 
of the A TP,Mg-dependent protein 
phosphatase 
Fig.3A depicts the dose-dependent inhibition of 
the active catalytic subunit by MBP, and the aboli- 
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Fig.2. Effect of MBP and ‘free modulator’ on the kinase 
FA-mediated activation of the ATP,Mg-dependent 
phosphatase. 50 mU F,M-enzyme were preincubated 
with (0) or without (0) 4,ug MBP or 50 ng modulator 
(A) in the presence of increasing concentrations 
(o-3000 mU per 30 ~1) of kinase FA, 0.1 mM ATP and 
0.5 mM Mg’+. The amount of activated F,M enzyme 
was measured by determining the phosphorylase 
phosphatase activity after a trypsin treatment. 
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Fig.3. Effect of MBP on the activity and stability of the 
isolated active phosphatase catalytic subunit. (A) 
Instantaneous inhibition of the active catalytic subunit 
by O-2.0 pg MBP in a 30 ycl phosphorylase phosphatase 
assay without (0) or after (0) a subsequent trypsin 
treatment. (B) Preincubation at 30°C of 250 mU of the 
active catalytic subunit with (0, A) or without (0, A) 
250 ng modulator, in the presence (A , A) or absence 
(0,O) of 2Opg MBP. The total preincubation mixture 
was 100 ,~l and at each interval a 20 pl aliquot was taken, 
treated with trypsin and its phosphorylase phosphatase 
activity determined as outlined in section 2. 
tion of this inhibition by subsequent proteolysis. 
With the substrate phosphorylase a at 20 PM in the 
assay, half-maximal inhibition is seen at about 
0.4pM MBP. This would suggest an enzyme- 
directed inhibition and not a substrate-directed ef- 
fect as also mentioned in [2]. In this respect also, 
MBP is very similar to the free modulator protein, 
which also inhibits the phosphorylase phosphatase 
activity at very low (nanomolar) concentrations 
1161. 
One very specific property of the modulator pro- 
tein is that it not only inhibits the phosphatase ac- 
tivity but also converts the active catalytic subunit 
of the ATP,Mg-dependent protein phosphatase to 
its inactive conformation in a time-dependent 
manner [1,5,10,17]. This is illustrated in fig.3B, 
where incubation of the active catalytic subunit 
with the modulator protein gradualiy decreased the 
phosphorylase phosphatase activity, as measured 
after a trypsin treatment, which destroys the inac- 
tive enzyme produced [5]. Incubation of catalytic 
subunit either alone or in the presence of MBP 
does not produce any inactive enzyme species, 
since the phosphorylase phosphatase activity in 
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both cases remains constant when measured after 
an identica1 trypsin treatment. Surprisingly, MBP 
was able to prevent the inactivation of the active 
catalytic subunit by the modulator protein 
(fig.3B). This observation is reminiscent of the 
stabilizing effect of the deinhibitor protein on the 
inactivation of the spontaneously active liver pro- 
tein phosphatase by the modulator [18], but the 
deinhibitor protein does not interfere in the activa- 
tion of the ATP,Mg-dependent phosphatase. 
The mechanism of stabilization of the active 
phosphatase conformation by MBP could be ex- 
plained in several ways. It is not very likely that, 
due to its very basic nature, MBP complexes itself 
with that portion of the acidic modulator molecule 
which binds to its high-affinity site on the catalytic 
subunit, since addition of MBP after a previous 
recombination of active catalytic subunit and 
modulator still prevents the inactivation (not 
shown). Moreover, other basic proteins such as 
protamine, lysine-rich histones or synthetically 
made polylysine do not stabilize the active confor- 
mation of the phosphatase. A more likely explana- 
tion would be that MBP and modulator compete 
for the same (high-affinity) binding site on the 
catalytic subunit which controls the inactivation of 
the enzyme [5,10]. It is equally possible however 
that MBP binds at a separate inhibitory site on the 
catalytic subunit and blocks the inactivation pro- 
cess in an allosteric manner. In either case, MBP or 
analogous proteins in other tissues may play a 
stabilizing role in the regulation of the ATP,Mg- 
dependent protein phosphatase activity. 
4. CONCLUSIONS 
The possible implication of MBP or MBP-like 
proteins in the regulation of the ATP,Mg- 
dependent phosphatase is a very intriguing one. Its 
abundance in the central and peripheral nervous 
system as a substrate for the myelin-associated 
kinase FA [3] could prevent the activation of the 
ATP ,Mg-dependent multisubstrate protein 
phosphatase, and thereby increase the 
phosphorylation level of many proteins in the 
myelin containing cells. Moreover, it inhibits the 
active form of this protein phosphatase, while 
keeping it in the active conformation. MBP does 
not seem to inhibit its own dephosphorylation [2] 
so that the activated ATP,Mg-dependent 
phosphatase may still function as an MBP 
phosphatase in vivo. 
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